1. Saudi Arabia Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Al-Razi Medical Co.

Al-Razi Medical Co.

9572.SR
Al-Razi Medical Co.SA flagSaudi Exchange
32.00
SAR
+0.22
- -
48.64MMarket Cap
Al-Razi Medical Co.
9572.SR
(Saudi Exchange)

Recent

price

32.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
FRC
34.47
40.35
40.36
- -
Revenue per Share
1.33
0.45
0.12
- -
Basic EPS, GAAP
1.35
0.47
0.72
- -
Free Cash Flow per Basic Share
- -
1.59
- -
- -
Dividend per Share
11.2
10.02
10.13
- -
Book Value per Share
15.35
14.4
14.66
- -
Tangible Book Value per Share
2
2
2
- -
Basic Weighted Avg Shares
52
61
61
74
Sales/Revenue/Turnover
5.55
2.82
1.34
2.65
Operating Margin (%)
3
4
4
4
Depreciation Expense
2
1
- -
1
Net Income, GAAP
16.94
36.82
66.8
23.31
Effective Tax Rate (%)
3.84
1.12
0.29
1.1
Profit Margin (%)
14
11
11
9
Working Capital
6
8
6
9
LT Debt
24
22
23
24
Total Equity
- -
3.33
0.84
4.49
Return on Invested Capital (%)
- -
3.9
1.38
5.51
Return on Capital (%)
- -
4.25
1.15
5.09
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
3.89%
Free Cash Flow
- -
- -
252.65%
Net Income, GAAP
- -
- -
365.96%
Sales/Revenue/Turnover
- -
- -
21.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
61
2024
- -
- -
- -
- -
61
2025
- -
- -
- -
- -
74

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.45
2024
- -
- -
- -
- -
0.12
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.59
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Sudarshan Pharma Industries Ltd. (SUDARSHAN.BO)
Corporativo Fragua, S.A.B. de C.V. (FRAGUAB.MX)
Sanai Health Industry Group Company Limited (1889.HK)
Parmax Pharma Limited (PARMAX.BO)
Chugai Pharmaceutical Co., Ltd. (CHGCF)
Royalty Pharma plc (RPRX)
Business
Al-Razi Medical Company Al-Razi Medical Company SJSC (9572.SR) is a Saudi Arabia-based healthcare distributor that specializes in supplying medical equipment, supplies, and related products to hospitals, clinics, medical centers, medical companies, and pharmacies. Founded in 1986 and headquartered in Dammam with operations across the Eastern, Central, Western, and Southern regions of the Kingdom through five branches, the company stores, sells, and markets a wide range of items including hospital beds; steam and suction devices; inhalation devices; masks; needles; oxygen masks; water bladders; bandages; gloves; and consumer healthcare products such as personal care, skin care, hair care, makeup, and accessories. Its primary customer base encompasses government and private healthcare institutions, with all sales concentrated in Saudi Arabia and recent revenue reaching approximately SAR 61.33 million in fiscal year 2023. In recent developments, Al-Razi Medical Company secured Islamic credit facilities from Al Rajhi Bank, including a SAR 3 million facility, and underwent board changes with the appointment of Abdulmajeed bin Abdulrahman Al-Arini as an independent board member at its extraordinary general meeting in May 2025; the company also reported lower net profit for fiscal year 2024 despite revenue growth and maintains a focus on expanding its distribution network in the medical equipment wholesale sector.